Last updated on February 2018

Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors

Brief description of study

This is an open-label, two-part, multiple study to evaluate the safety and tolerability of DS-8201a in patients with advanced solid malignant tumors.

Detailed Study Description

This study is one single group of participants in two periods. It is therefore not randomized. The dosage strength will change during the study but all participants will receive the same study drug DS-8201a. So the study is not a true 2 arm study, it is a 2 part study.

Clinical Study Identifier: NCT02564900

Contact Investigators or Research Sites near you

Start Over

(For Japan sites only) Daiichi ...

Aichi Cancer Center Hospital
Aichi, Japan
  Connect »